Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Heart Test Laboratories's Enterprise Value is $-2.20 Mil.
Heart Test Laboratories's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-6.02 Mil. Therefore, Heart Test Laboratories's EV-to-EBIT ratio for today is 0.36.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Heart Test Laboratories's Enterprise Value
For the Medical Devices subindustry, Heart Test Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Heart Test Laboratories's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Heart Test Laboratories's Enterprise Value falls into.
Heart Test Laboratories Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Heart Test Laboratories's Enterprise Value for the fiscal year that ended in Apr. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Heart Test Laboratories (NAS:HSCS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Heart Test Laboratories's current Enterprise Value is $-2.20 Mil.
Heart Test Laboratories's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.02 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Heart Test Laboratories's EV-to-EBITDA for today is:
Heart Test Laboratories's current Enterprise Value is $-2.20 Mil.
Heart Test Laboratories's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.00 Mil.
Heart Test Laboratories's current Enterprise Value is $-2.20 Mil.
Heart Test Laboratories's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Heart Test Laboratories Enterprise Value Related Terms
Thank you for viewing the detailed overview of Heart Test Laboratories's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Heart Test Laboratories (Heart Test Laboratories) Business Description
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSCS has been successfully added to your 